Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 8 studies | 34% ± 17% | |
intestine | 7 studies | 25% ± 10% | |
brain | 6 studies | 31% ± 13% | |
peripheral blood | 5 studies | 19% ± 3% | |
pancreas | 4 studies | 45% ± 20% | |
kidney | 4 studies | 19% ± 4% | |
placenta | 3 studies | 33% ± 11% | |
eye | 3 studies | 24% ± 9% | |
uterus | 3 studies | 31% ± 15% | |
lymph node | 3 studies | 27% ± 7% | |
breast | 3 studies | 22% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 5814.42 | 258 / 258 | 100% | 33.24 | 230 / 230 |
bladder | 100% | 4559.57 | 21 / 21 | 100% | 49.20 | 504 / 504 |
esophagus | 100% | 5914.80 | 1445 / 1445 | 100% | 43.83 | 183 / 183 |
intestine | 100% | 5395.73 | 966 / 966 | 100% | 41.73 | 527 / 527 |
kidney | 100% | 4373.12 | 89 / 89 | 100% | 34.35 | 901 / 901 |
ovary | 100% | 4742.77 | 180 / 180 | 100% | 29.54 | 430 / 430 |
skin | 100% | 6847.55 | 1809 / 1809 | 100% | 52.09 | 472 / 472 |
thymus | 100% | 5215.64 | 653 / 653 | 100% | 37.18 | 605 / 605 |
uterus | 100% | 4499.07 | 170 / 170 | 100% | 55.98 | 459 / 459 |
brain | 100% | 4897.99 | 2639 / 2642 | 100% | 31.32 | 705 / 705 |
prostate | 100% | 4530.14 | 245 / 245 | 100% | 33.49 | 501 / 502 |
lung | 100% | 4924.57 | 577 / 578 | 100% | 41.65 | 1154 / 1155 |
breast | 100% | 4831.72 | 459 / 459 | 100% | 35.33 | 1114 / 1118 |
liver | 100% | 3144.28 | 226 / 226 | 100% | 31.93 | 404 / 406 |
stomach | 100% | 5425.70 | 359 / 359 | 99% | 35.38 | 284 / 286 |
pancreas | 99% | 2729.60 | 326 / 328 | 99% | 41.33 | 177 / 178 |
adipose | 100% | 4939.56 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 5524.48 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 29.47 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 28.03 | 29 / 29 |
spleen | 100% | 4102.37 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 44.11 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 41.69 | 1 / 1 |
heart | 99% | 4217.08 | 855 / 861 | 0% | 0 | 0 / 0 |
muscle | 98% | 1990.59 | 790 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 85% | 2337.64 | 787 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0034314 | Biological process | Arp2/3 complex-mediated actin nucleation |
GO_0030036 | Biological process | actin cytoskeleton organization |
GO_0015629 | Cellular component | actin cytoskeleton |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005885 | Cellular component | Arp2/3 protein complex |
GO_0005829 | Cellular component | cytosol |
GO_0035861 | Cellular component | site of double-strand break |
GO_0036195 | Cellular component | muscle cell projection membrane |
GO_0005634 | Cellular component | nucleus |
GO_0051015 | Molecular function | actin filament binding |
GO_0003779 | Molecular function | actin binding |
Gene name | ARPC1A |
Protein name | Actin-related protein 2/3 complex subunit 1A (SOP2-like protein) Actin related protein 2/3 complex subunit 1A Uncharacterized protein ARPC1A |
Synonyms | SOP2L |
Description | FUNCTION: Probably functions as a component of the Arp2/3 complex which is involved in regulation of actin polymerization and together with an activating nucleation-promoting factor (NPF) mediates the formation of branched actin networks. . |
Accessions | ENST00000432786.5 Q75MY0 Q92747 E9PF58 ENST00000262942.10 [Q92747-1] |